GENERAL RELEASE and CHANGE of STATUS AGREEMENTGeneral Release and Change of Status Agreement • March 17th, 2017 • Oxygen Therapy, Inc. • Pharmaceutical preparations • Massachusetts
This General Release and Change of Status Agreement (the “Agreement”) is made and entered into by and between Ache Stokelman (“Executive”) and Oxygen Therapy, Inc. (“Company”) this 10th day of March, 2017 (the “Separation Date”).
SUBSCRIPTION AGREEMENT Boston Therapeutics, Inc. Manchester, NH 03104 Tel. (603) 935-9799Subscription Agreement • March 17th, 2017 • Oxygen Therapy, Inc. • Pharmaceutical preparations
THIS SUBSCRIPTION AGREEMENT made this _____day of ______________, 2012 by and between Boston Therapeutics, Inc., a Delaware corporation (hereinafter “Company”), and the undersigned Subscriber (hereinafter “Subscriber”), who, for and in consideration of the mutual promises and covenants set forth herein, do hereto agree as follows:
AMENDMENT NO. 1 TO VOTING AGREEMENTVoting Agreement • March 17th, 2017 • Oxygen Therapy, Inc. • Pharmaceutical preparations
This Amendment No. 1 to Voting Agreement, dated as of March 10, 2017 (the “Amendment”) is made by and among David Platt, Yuval Kwintner and Ache Ezer Stokelman (collectively, the “Holders.”) and Oxygen Therapy, Inc., a Delaware corporation (the “Company”)..
